Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease GWASCAT Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. 22885922 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease GWASDB Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. 22325160 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. 22038520 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE Recently, the association of the natural variants rs1260326 and rs780094 of the glucokinase regulatory protein (GCKR) gene with increased fasting triglycerides and decreased fasting plasma glucose in diabetic adults was reported; the minor alleles were also found to reduce the risk of type 2 diabetes. 21511510 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE Four of the 34 risk loci for type 2 diabetes or hyperglycemia (GCKR, FADS1, NOTCH2, and HNF1B) were significantly associated with lipoprotein traits. 21421807 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE Genotyping GCKR in patients with newly diagnosed type 2 diabetes might help in identifying patients at high risk for metabolic derangements or CKD. 21411509 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE GCKR variation did not predict development of type 2 diabetes. 21525158 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE The rs3817588 A/G polymorphism of the GCKR gene was associated with type 2 diabetes and plasma triglyceride level in the Han Chinese population. 21569451 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE GCKR mutations in Japanese families with clustered type 2 diabetes. 21236713 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE We showed that SNPs from GCK, G6PC2 and MTNR1B modulated the fasting glucose levels in the normoglycaemic population while SNPs from G6PC2 and GCKR was associated with type 2 diabetes. 20668700 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE In this review we describe the progress that has been made to date in translating association signals into molecular mechanisms with a focus on the most tractable signals (eg, KCNJ11/ABCC8, SLC30A8, GCKR) and those in which human, animal, and cellular models (FTO, TCF7L2, G6PC2) have provided insights into the role in T2D pathogenesis. 20878272 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG). 20628598 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? 21114848 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE A meta-analysis confirmed the association of GCKR rs780094 with T2DM susceptibility. 20574426 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease CTD_human We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. 20081858 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. 20081858 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE The GCKR rs780094 was also associated with obesity and BMI, independently of its association with type 2 diabetes. 19241058 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated. 18556336 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease BEFREE The minor GCKR A-allele of rs780094 is associated with an increased level of fasting serum triacylglycerol (p = 6 x 10(-14)), impaired fasting (p = 0.001) and OGTT-related insulin release (p = 3 x 10(-6)), reduced homeostasis model assessment of insulin resistance (p = 0.0004), WHO-defined dyslipidaemia (p = 6 x 10(-9)) and a modestly decreased risk of type 2 diabetes (p = 0.01). 18008060 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.500 GeneticVariation disease GWASDB Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. 17463246 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE The glucokinase regulatory protein gene is a candidate gene for Type 2 diabetes. 16401311 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.500 Biomarker disease BEFREE Additionally, introduction of the glucokinase regulatory protein and protein kinase C-zeta have been shown to improve glucose tolerance in non-insulin-dependent diabetes mellitus animal models. 15891936 2005